Midway Immunology and Research Center

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• HIV3 trials

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Gilead Sciences3 trials

Running trials

• Recruiting

  Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

  NCT07682961· Phase 3· Gilead Sciences· Source

• Active, not recruiting

  Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)

  NCT07047716· Phase 3· Gilead Sciences· Source

• Active, not recruiting

  Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV

  NCT05052996· Phase 2· Gilead Sciences· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• HIV1 recruiting